Effect of Pemetrexed combined with cis-platinum chemotherapy on matrix metalloproteinase VEGF, NK cells and immune function in patients with non-squamous non-small cell lung cancer
Objective: To explore effect of Pemetrexed combined with cis-platinum chemotherapy on matrix metalloproteinase (MMPs), vascular esandothelial growth factor (VEGF), NK cells and immune function in patients with non-squamous non-small cell lung cancer. Method: A total of 86 cases of non-squamous no...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Editorial Board of Journal of Hainan Medical University
2017-07-01
|
Series: | Journal of Hainan Medical University |
Subjects: | |
Online Access: | http://www.hnykdxxb.com/PDF/201713/28.pdf |
id |
doaj-093e03e8630e463daa883c84557137a2 |
---|---|
record_format |
Article |
spelling |
doaj-093e03e8630e463daa883c84557137a22020-11-25T01:41:49ZengEditorial Board of Journal of Hainan Medical UniversityJournal of Hainan Medical University1007-12371007-12372017-07-012313110113Effect of Pemetrexed combined with cis-platinum chemotherapy on matrix metalloproteinase VEGF, NK cells and immune function in patients with non-squamous non-small cell lung cancerFeng Wen0Yan Xiang1Shao-Long Wang2Department of Oncology, The First Affiliated Hospital of Chengdu Medical College, 610500 Chengdu, ChinaGynecology department, Chengdu Xindu Hospital of traditional Chinese Medicine,610500 Chengdu, ChinaDepartment of Oncology, The First Affiliated Hospital of Chengdu Medical College, 610500 Chengdu, ChinaObjective: To explore effect of Pemetrexed combined with cis-platinum chemotherapy on matrix metalloproteinase (MMPs), vascular esandothelial growth factor (VEGF), NK cells and immune function in patients with non-squamous non-small cell lung cancer. Method: A total of 86 cases of non-squamous non-small cell lung cancer patients were divided into control group (n=44) and observation group (n=42), control group was given docetaxel combined cisplatinum chemotherapy, pemetrexed combined cis-platinum chemotherapy, was applied for observation group. Compared MMP-2, MMP-9, VEGF, NK cells and immune function level before and after treatment in both groups. Results: MMP-2, MMP-9, VEGF, NK cells, CD3+, CD4+, CD8+, CD4+/CD8+ level in both groups before treatment was no significant difference. After treatment, MMP-2, MMP-9, VEGF, CD8+level in both groups was significant lower than before treatment intra-group, and observation was lower than control group, there was significant difference. After treatment, NK cells, CD3+, CD4+, CD8+, CD4+/CD8+ level in both groups was increased dramatically than before treatment of intra-group, moreover, NK cells, CD3+, CD4+, CD8+, CD4+/CD8+level in observation group after treatment was obvious higher than in control group after treatment, there was significant difference. Conclusion: Pemetrexed combined with cis-platinum chemotherapy for non-squamous non-small cell lung cancer could effectively decrease serum MMPs, VEGF level and increase NK cell level, regulate immune function, with definite clinical significance.http://www.hnykdxxb.com/PDF/201713/28.pdfNon-squamous non-small cell lung cancerpemetrexedCis-platinumMetalloproteinaseVascular endothelial growth factorImmune function |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Feng Wen Yan Xiang Shao-Long Wang |
spellingShingle |
Feng Wen Yan Xiang Shao-Long Wang Effect of Pemetrexed combined with cis-platinum chemotherapy on matrix metalloproteinase VEGF, NK cells and immune function in patients with non-squamous non-small cell lung cancer Journal of Hainan Medical University Non-squamous non-small cell lung cancer pemetrexed Cis-platinum Metalloproteinase Vascular endothelial growth factor Immune function |
author_facet |
Feng Wen Yan Xiang Shao-Long Wang |
author_sort |
Feng Wen |
title |
Effect of Pemetrexed combined with cis-platinum chemotherapy on matrix metalloproteinase VEGF, NK cells and immune function in patients with non-squamous non-small cell lung cancer |
title_short |
Effect of Pemetrexed combined with cis-platinum chemotherapy on matrix metalloproteinase VEGF, NK cells and immune function in patients with non-squamous non-small cell lung cancer |
title_full |
Effect of Pemetrexed combined with cis-platinum chemotherapy on matrix metalloproteinase VEGF, NK cells and immune function in patients with non-squamous non-small cell lung cancer |
title_fullStr |
Effect of Pemetrexed combined with cis-platinum chemotherapy on matrix metalloproteinase VEGF, NK cells and immune function in patients with non-squamous non-small cell lung cancer |
title_full_unstemmed |
Effect of Pemetrexed combined with cis-platinum chemotherapy on matrix metalloproteinase VEGF, NK cells and immune function in patients with non-squamous non-small cell lung cancer |
title_sort |
effect of pemetrexed combined with cis-platinum chemotherapy on matrix metalloproteinase vegf, nk cells and immune function in patients with non-squamous non-small cell lung cancer |
publisher |
Editorial Board of Journal of Hainan Medical University |
series |
Journal of Hainan Medical University |
issn |
1007-1237 1007-1237 |
publishDate |
2017-07-01 |
description |
Objective: To explore effect of Pemetrexed combined with cis-platinum chemotherapy on
matrix metalloproteinase (MMPs), vascular esandothelial growth factor (VEGF), NK cells and
immune function in patients with non-squamous non-small cell lung cancer. Method: A total
of 86 cases of non-squamous non-small cell lung cancer patients were divided into control
group (n=44) and observation group (n=42), control group was given docetaxel combined cisplatinum
chemotherapy, pemetrexed combined cis-platinum chemotherapy, was applied for
observation group. Compared MMP-2, MMP-9, VEGF, NK cells and immune function level
before and after treatment in both groups. Results: MMP-2, MMP-9, VEGF, NK cells, CD3+,
CD4+, CD8+, CD4+/CD8+ level in both groups before treatment was no significant difference.
After treatment, MMP-2, MMP-9, VEGF, CD8+level in both groups was significant lower
than before treatment intra-group, and observation was lower than control group, there was
significant difference. After treatment, NK cells, CD3+, CD4+, CD8+, CD4+/CD8+ level in both
groups was increased dramatically than before treatment of intra-group, moreover, NK cells,
CD3+, CD4+, CD8+, CD4+/CD8+level in observation group after treatment was obvious higher
than in control group after treatment, there was significant difference. Conclusion: Pemetrexed
combined with cis-platinum chemotherapy for non-squamous non-small cell lung cancer could
effectively decrease serum MMPs, VEGF level and increase NK cell level, regulate immune
function, with definite clinical significance. |
topic |
Non-squamous non-small cell lung cancer pemetrexed Cis-platinum Metalloproteinase Vascular endothelial growth factor Immune function |
url |
http://www.hnykdxxb.com/PDF/201713/28.pdf |
work_keys_str_mv |
AT fengwen effectofpemetrexedcombinedwithcisplatinumchemotherapyonmatrixmetalloproteinasevegfnkcellsandimmunefunctioninpatientswithnonsquamousnonsmallcelllungcancer AT yanxiang effectofpemetrexedcombinedwithcisplatinumchemotherapyonmatrixmetalloproteinasevegfnkcellsandimmunefunctioninpatientswithnonsquamousnonsmallcelllungcancer AT shaolongwang effectofpemetrexedcombinedwithcisplatinumchemotherapyonmatrixmetalloproteinasevegfnkcellsandimmunefunctioninpatientswithnonsquamousnonsmallcelllungcancer |
_version_ |
1725039462042304512 |